Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases.

Rowan S Hardy, Karim Raza, Mark S Cooper

Nature reviews. Rheumatology 2020 Mar

filter terms:

Therapeutic glucocorticoids have been widely used in rheumatic diseases since they became available over 60 years ago. Despite the advent of more specific biologic therapies, a notable proportion of individuals with chronic rheumatic diseases continue to be treated with these drugs. Glucocorticoids are powerful, broad-spectrum anti-inflammatory agents, but their use is complicated by an equally broad range of adverse effects. The specific cellular mechanisms by which glucocorticoids have their therapeutic action have been difficult to identify, and attempts to develop more selective drugs on the basis of the action of glucocorticoids have proven difficult. The actions of glucocorticoids seem to be highly cell-type and context dependent. Despite emerging data on the effect of tissue-specific manipulation of glucocorticoid receptors in mouse models of inflammation, the cell types and intracellular targets of glucocorticoids in rheumatic diseases have not been fully identified. Although showing some signs of decline, the use of systemic glucocorticoids in rheumatology is likely to continue to be widespread, and careful consideration is required by rheumatologists to balance the beneficial effects and deleterious effects of these agents.

Citation

Rowan S Hardy, Karim Raza, Mark S Cooper. Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases. Nature reviews. Rheumatology. 2020 Mar;16(3):133-144